Clinical Trials Logo
  1. Home
  2. Neuromuscular Manifestations
  3. NCT04931901

Paired Assessment of Two Electromyographic Neuromuscular Monitors: Stimpod NMX450X Versus Datex-Ohmeda E-NMT

Neuromuscular Manifestations Clinical Trial

Official title:
Paired Assessment of Two Electromyographic Neuromuscular Monitors: Stimpod NMX450X Versus Datex-Ohmeda E-NMT

Clinical Trial Summary

After anesthesia is induced, 2 EMG TOFF devices will be placed on the patients arms, one on the right arm, the other on the left. There will be a randomization per dominant hand and nondominant hand for the placing of the devices. The devices are the Stimpod NMX450X and the Datex-Ohmeda E-NMT.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04931901
Study type Interventional
Source Universitair Ziekenhuis Brussel
Contact Evelien Vandeurzen, MSC
Phone 024749237
Email evelien.vandeurzen@uzbrussel.be
Status Recruiting
Phase N/A
Start date September 6, 2021
Completion date December 31, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Recruiting NCT06381284 - Feasibility of Engaging and Capturing Undiagnosed Myasthenia Gravis Participants Through a Social Media Campaign Paired With a Self-moderated Assessment
Completed NCT03471923 - Non-Motor Features of Cervical Dystonia (CD)
Completed NCT02689544 - Effects of Static Stretching and Dynamic in Flexibility and Performance: Blind and Randomized Clinical Trial N/A
Completed NCT05738200 - Nordic Hamstring Exercise After ACL Reconstruction Reconstruction N/A
Completed NCT03250988 - Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility
Completed NCT03209960 - Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity
Completed NCT03211390 - Using Telemedicine to Improve Spasticity Diagnosis Rates
Active, not recruiting NCT05156320 - Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam Phase 3
Completed NCT03221439 - Cognitive Functional Therapy for Chronic Low Back Pain N/A
Completed NCT03921528 - An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy Phase 2
Active, not recruiting NCT05626855 - Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX Phase 3
Recruiting NCT05810272 - Impact of Postprandial 'Exercise Snacks' on Protein and Glucose Metabolism Following a Period of Step Reduction in Older Adults N/A